J Korean Diabetes > Volume 11(3); 2010 > Article
The Journal of Korean Diabetes 2010;11(3):165-171.
DOI: https://doi.org/10.4093/kcd.2010.11.3.165   
레닌-안지오텐신 시스템 억제제와 당뇨병의 예방
유지희, 이우제
Renin-Angiotensin System Inhibitors and Prevention of Diabetes
Ji Hee Yu, Woo Je Lee
Abstract
Type 2 diabetes mellitus (T2DM) is a major health problem all over the world. To reduce the burden from T2DM, prevention of the disease should be considered as a key objective in the near future. A growing number of experimental and clinical studies have provided evidences that pharmacological blockade of the renin-angiotensin system (RAS) by either angiotensin-converting enzyme (ACE) inhibitors or angiotensin receptor blockers (ARBs) might reduce the incidence of new onset T2DM in high-risk subjects. The beneficial effects of RAS inhibition on the development of diabetes have been largely attributed to improvement in peripheral insulin sensitivity and glucose metabolism. However, the main mechanism of the protective effect of ACE inhibitors or ARBs remain to be determined. In addition, prospective, randomized controlled studies are still needed to further elucidate their exact roles in diabetes prevention. (Korean Clinical Diabetes J 11:165-171, 2010)
Key Words: Angiotensin converting enzyme inhibitors, Angiotensin receptor blockers, Diabetes mellitus, Prevention, Renin-angiotensin system


Editorial Office
101-2104, Lotte Castle President, 109 Mapo-daero, Mapo-gu, Seoul 04146, Korea​
Tel: +82-2-714-9064    Fax: +82-2-714-9084    E-mail: diabetes@kams.or.kr                

Copyright © 2021 by Korean Diabetes Association. All rights reserved.

Developed in M2PI

Close layer